Reuters logo
BRIEF-Eyegate Pharmaceuticals reports full-year 2016 financial results
February 23, 2017 / 9:24 PM / 9 months ago

BRIEF-Eyegate Pharmaceuticals reports full-year 2016 financial results

Feb 23 (Reuters) - Eyegate Pharmaceuticals Inc-

* Eyegate Pharmaceuticals reports full-year 2016 financial results and provides business update

* Eyegate Pharmaceuticals Inc - cash and cash equivalents as of December 31, 2016 totaled $3.6 million, compared with $8.4 million as of December 31, 2015

* Eyegate Pharmaceuticals-cash, cash equivalents as of Dec 31, 2016 does not include upfront payment received in conjunction with valeant licensing agreement Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below